pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
fda medwatch·Aug 28·1 min read
save

Boston Scientific recalls Imager II angiographic catheters over tip detachment risk

Aug 28, 2026·read at fda medwatch ↗RegulatoryNegative

FDA's CDRH issued an Early Alert about Boston Scientific's Imager II angiographic catheters due to a manufacturing problem that can cause the catheter tip to detach.

The company sent a letter on August 24 advising customers to stop using or distributing the devices, to segregate any inventory, and to follow standard care for patients already treated.

Facilities are instructed to check both inner and outer packaging codes when locating the affected catheters and to complete the provided Reply Verification Tracking Form for reporting.

source

This writeup was produced by pharmadog from original reporting by fda medwatch.

Original headline: “Early Alert: Angiographic Catheter Issue from Boston Scientific”

read at fda medwatch ↗
678 words · retrieved Aug 28
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
BOSTON SCIENTIFIC CORP10UNIQUE2LEADING
topics
Hematology

related stories

  • Sep 25Angiographic Catheter Recall: Boston Scientific Removes Imager II Angiographic Cathetersfda medwatch
  • 9h agoCaribou to stop R&D work, start ‘substantial’ job cutsBioSpace
  • 3d agoInfusion Set Recall: BD and CareFusion 303, Inc. Remove BD Alaris Pump Infusion Setsfda medwatch
  • Sep 21Behind the outcomes: How whole-patient support is reshaping oncology careBioPharma Dive
  • Sep 7BrainChild Bio masterminds $116M series A for CAR-T's pivotal push in pediatric brain cancerFierce Biotech